Skip to main content

Table 2 Suppression of tumor growth by DHMEQ in combination with paclitaxel in T24PR mouse xenograft model

From: Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

  tumor volume (mm3) apoptotic index (%) proliferation index (%)
control 486.3 ± 25.3 1.5 ± 0.3 83.7 ± 3.3
paclitaxel 403.8 ± 36.3* 3.9 ± 0.9* 69.1 ± 4.8*
palitaxel + DHMEQ 160.8 ± 20.3*, ** 10.0 ± 0.8*, ** 34.3 ± 3.6*, **
  1. *P < 0.05 compared with control; **P < 0.05 compared with paclitaxel.